Species diversity and methicillin resistance in Staphylococcus spp. in nosocomial infections | CMAC

Species diversity and methicillin resistance in Staphylococcus spp. in nosocomial infections

Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):207-211

​ Barantsevich N.E., Barantsevich E.P.
10.36488/cmac.2019.3.207-211
staphylococci S. aureus coagulase-negative staphylococci methicillin resistance nosocomial infections
Section
Diseases and Pathogens
Type
Original Article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):207-211

Objective.

To evaluate Staphylococcus species diversity and methicillin resistance in nosocomial infections.

Materials and Methods.

Staphylococci isolated from blood, bronchoalveolar lavage fluid, cerebrospinal fluid, post-operative wound exudates, urine and other samples were identified to species level with MALDITOF mass-spectrometry. Methicillin resistance was evaluated according to EUCAST guidelines.

Results.

A total of 3239 consecutive Staphylococcus strains isolated in a tertiary-care medical centre, accumulating patients from all Russian regions were identified in 2016–2017 as 1460 (45.1%) of S. aureus strains and 1779 (54.9%) of coagulase-negative staphylococci, presenting 12 species (S. epidermidis, S. haemolyticus, S. hominis, S capitis, S. warneri, S. lugdunensis, S. simulans, S. caprae, S. saprophyticus, S. cohnii, S. sciuri, S. auricularis). S. epidermidis was isolated in 1164 (35.9%) samples, S. haemolyticus – in 305 (9.4%), S. hominis in 215 (6.6%), S. capitis in 46 (1.4%) cases. Other Staphylococcus spp. were isolated from less than 1% of samples. Methicillin-resistant were 1628 (50.3%) Staphylococcus strains, including 202 (13.8%) S. aureus isolates, 933 (80.2%) – S. epidermidis, 283 (92.5%) – S. haemolyticus, 182 (84.7%) – S. hominis, 8 (17.4%) – S. capitis.

Conclusions.

Significant species diversity in staphylococci, isolated from patients samples in a multidisciplinary medical center in Saint-Petersburg in 2016–2017, was revealed. S. aureus prevailed in nosocomial infections of different localizations, accounting for more than a half of isolated Staphylococcus spp. Among coagulase-negative staphylococci 1⁄3 of isolated strains were S. epidermidis (the most common species in this group). Methicillin resistance was found in a half of Staphylococcus spp. strains. The level of methicillin-resistance in S. aureus was 13.8%, with decrease from 15.6% in 2016 to 12.3% in 2017. S. haemolyticus, S. hominis and S. epidermidis showed the highest level of methicillin resistance (more than 80%). All of the S. auricularis, S. cohnii, S. caprae, S. lugdunensis and S. sciuri isolates were methicillin-susceptible.

Barantsevich N.E.

Almazov National Medical Research Centre, Saint-Petersburg, Russia

Elena P. Barantsevich

Almazov National Medical Research Centre, Saint-Petersburg, Russia

  • 1. Tong S., Davis J.S., Eichenberger E., Holland T.L., Fowler V.G. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Сlin Microbiol Rev. 2015;28(3):603-661. DOI: 10.1128/CMR.00134-14
  • 2. Giormezis N., Kolonitsiou F., Foka A., Drougka E., Liakopoulos A., Makri A., et al. Coagulase-negative staphylococcal bloodstream and prosthetic-device-associated infections: the role of biofilm formation and distribution of adhesin and toxin geneS. J Med Microbiol. 2014;63(Pt 11):1500-1508. DOI: 10.1099/jmm.0.075259-0
  • 3. Chastre J., Blasi F., Masterton R.G., Rello J., Torres A., Welte T. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clin Microbiol Infect. 2014;20(4):19-36. DOI: 10.1111/1469-0691.12450
  • 4. Shittu A., Oyedara O., Abegunrin F., Okon K., Raji A., Taiwo S., et al. Characterization of methicillin-susceptible and -resistance staphylococci in the clinical setting: a multicentre study in Nigeria. BMC Infect DiS. 2012;12:286. DOI: 10.1186/1471-2334-12-286
  • 5. Klein E., Smith D.L., Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect DiS. 2007;13(12):1840-1846. DOI: 10.3201/eid1312.070629
  • 6. Bassetti M., Peghin M., Trecarichi E. M., Carnelutti A., Righi E., Del Giacomo P., et al. Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality. PLoS One. 2017;12(2):e0170236. DOI: 10.1371/journal.pone.0170236
  • 7. Romanov А.V., Dekhnich А.V., Edelstein М.V. Molecular epidemiology of Staphylococcus aureus in Russian pediatric hospitalS. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2012;11(3):201-208. Russian.
  • 8. Dekhnich A.V., Nikulin A.A., Ryabkova E.L., Krechikova O.I., Sukhorukova M.V., Kozlov R.S., et al. Epidemiology of antimicrobial resistance of S. aureus isolated from ICU patients in Russia: results of prospective multicenter study. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2008;10(4):333-344. Russian.
  • 9. Vishnevsky A.A., Babak S.V. Nonspecific osteomyelitis of the spine caused by methicillin-resistant Staphylococcus: rational antibiotic treatment. Trudnyj pacient. 2014;12(3):39-43. Russian.
  • 10. Rasheed M., Awole M. Staphylococcus epidermidis: a commensal emerging as a pathogen with increasing clinical significance especially in nosocomial infectionS. Internet J Microbiol. 2006;3(2):1-8.
  • 11. Rupp M.E., Archer G.L. Coagulase-negative staphylococci: pathogens associated with medical progresS. Clin Infect DiS. 1994;19(2):231-243. DOI: 10.1093/clinids/19.2.231
  • 12. Darouiche R.O. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect DiS. 2001;33(9):1567-1572. DOI: 10.1086/323130
  • 13. Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29(11):996-1011. DOI: 10.1086/591861
  • 14. Geffers C., Gastmeier P. Nosocomial infections and multidrugresistant organisms in Germany: epidemiological data from KISS (the Hospital Infection Surveillance System). Dtsch Arztebl Int. 2011;108(6):87-93. DOI: 10.3238/arztebl.2011.0087
  • 15. Fontela P.S., Platt R.W., Rocher I., Frenette C., Moore D., Fortin É., et al. Surveillance provinciale des infections nosocomiales (SPIN) program: implementation of a mandatory surveillance program for central line-associated bloodstream infectionS. Am J Infect Control. 2011;39(4):329-335. DOI: 10.1016/j.ajic.2010.07.007
  • 16. Hur J., Lee A., Hong J., Jo W.Y., Cho O.H., Kim S., et al. Staphylococcus saprophyticus bacteremia originating from urinary tract infections: a case report and literature review. Infect Chemother. 2016;48(2):136-139. DOI: 10.3947/ic.2016.48.2.136
Views
0 Abstract
0 PDF
0 Crossref citations
Shared